Anti-EWSR1 Antibody Picoband® (monoclonal, 4B4) Fluoro647 Conjugated

This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t (11;22) (q24; q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14.

Cancer Susceptibility, Cell Type Markers, Chromatin Binding Proteins, DNA/RNA Binding, Epigenetics and Nuclear Signaling, Proto-Oncogenes, Tags & Cell Markers, Transcription, Transcription Factors, Tumor Associated

Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.

1. Entrez Gene: EWSR1 Ewing sarcoma breakpoint region 1. 2. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G (October 1992) . Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359 (6391) : 162–5.